Primary Site >> Colorectal Cancer
Gene >> HLA-A
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Ref: Cell surface antigens of human renal cancer defined by mouse monoclonal antibodies: identification of tissue-specific kidney glycoproteins. PMID: 6946460 |
Ref: Lack of expression of HLA-ABC antigens in choriocarcinoma and other human tumor cell lines. PMID: 6181407 |
Ref: Differential gamma-interferon response of human colon carcinoma cells: inhibition of proliferation and modulation of immunogenicity as independent effects of gamma-interferon on tumor cell growth. PMID: 3160456 Ref: Full expression of blood group-related, transplantation-related, and carcinoembryonic antigens in human colorectal cancer cells with different degrees of phenotypic differentiation. PMID: 3856476 |
Ref: Loss of HLA-A,B,C and de novo expression of HLA-D in colorectal cancer. PMID: 2417962 Ref: Loss of HLA-A,B,C in colorectal carcinoma is related to the degree of de-differentiation. PMID: 3469275 |
Ref: Reduction or loss of HLA-A,B,C antigens in colorectal carcinoma appears not to influence survival. PMID: 2839218 Ref: Loss of polymorphic A and B locus HLA antigens in colon carcinoma. PMID: 3291922 |
Ref: Selective loss of HLA-A or HLA-B antigen expression in colon carcinoma. PMID: 2462591 Ref: Loss of HLA-A,B,C allele products and lymphocyte function-associated antigen 3 in colorectal neoplasia. PMID: 2473473 Ref: Selective loss of beta 2-microglobulin mRNA in human colon carcinoma. PMID: 2642530 |
Ref: Frequency of abnormal expression of HLA-A,B,C and HLA-DR molecules, invariant chain, and LFA-3 (CD58) in colorectal carcinoma and its impact on tumor recurrence. PMID: 1712347 Ref: Polymerase chain reaction analysis of transcriptional patterns of expression of class I HLA genes. PMID: 1774198 Ref: Regulation of the expression of major histocompatibility complex class I genes in human colorectal cancer. PMID: 1905582 Ref: Regulation of HLA class I gene expression in human colorectal carcinoma. PMID: 1912515 Ref: MHC expression on human tumors--its relevance for local tumor growth and metastasis. PMID: 1912516 |
Ref: The role of surface HLA-A,B,C molecules in tumour immunity. PMID: 1423320 Ref: Locus-specific transcriptional control of HLA genes. PMID: 1517566 Ref: Loss of HLA class-I alleles, heavy chains and beta 2-microglobulin in colorectal cancer. PMID: 1592528 |
Ref: Expression of APO-1 (CD95), a member of the NGF/TNF receptor superfamily, in normal and neoplastic colon epithelium. PMID: 8168998 Ref: Lithocholic acid inhibits the expression of HLA class I genes in colon adenocarcinoma cells. Differential effect on HLA-A, -B and -C loci. PMID: 8196671 |
Ref: MHC class I bound peptides of a colon carcinoma cell line, a Ki-ras gene-targeted progeny cell line and a B cell line. PMID: 9489488 Ref: High frequency of altered HLA class I phenotypes in invasive colorectal carcinomas. PMID: 9756399 |
Ref: Antibody-conjugated MHC class I tetramers can target tumor cells for specific lysis by T lymphocytes. PMID: 11093131 |
Ref: Expression of tumor rejection antigens in colorectal carcinomas. PMID: 11920522 Ref: Alternatively spliced forms of MICA and MICB lacking exon 3 in a human cell line and evidence of presence of similar RNA in human peripheral blood mononuclear cells. PMID: 12466900 Ref: Down-regulation of HLA-A expression correlates with a better prognosis in colorectal cancer patients. PMID: 12480922 |
Ref: Treatment of colon and breast carcinoma cells with 5-fluorouracil enhances expression of carcinoembryonic antigen and susceptibility to HLA-A(*)02.01 restricted, CEA-peptide-specific cytotoxic T cells in vitro. PMID: 12584740 Ref: Differences in T-cell immunity toward tumor-associated antigens in colorectal cancer and breast cancer patients. PMID: 12673683 Ref: Total loss of MHC class I in colorectal tumors can be explained by two molecular pathways: beta2-microglobulin inactivation in MSI-positive tumors and LMP7/TAP2 downregulation in MSI-negative tumors. PMID: 12694570 Ref: EphA2 as target of anticancer immunotherapy: identification of HLA-A*0201-restricted epitopes. PMID: 14679012 |
Ref: Immune system and prognosis in colorectal cancer: a detailed immunohistochemical analysis. PMID: 14968119 Ref: p53 and HLA class-I expression are not down-regulated in colorectal cancer liver metastases. PMID: 15065606 |
Ref: Dendritic cell-mediated cross-presentation of antigens derived from colon carcinoma cells exposed to a highly cytotoxic multidrug regimen with gemcitabine, oxaliplatin, 5-fluorouracil, and leucovorin, elicits a powerful human antigen-specific CTL response PMID: 16002679 |
Ref: Inverse correlation between HLA-DR antigen expression and CD4 positive lymphocytic populations in normal mucosa, tubulovillous adenoma, and invasive carcinoma of the colon. PMID: 16715627 |
Ref: Identification of an HLA-A*0201 restricted Bcl2-derived epitope expressed on tumors. PMID: 17182178 Ref: Immunogenicity of the carcinoembryonic antigen derived peptide 694 in HLA-A2 healthy donors and colorectal carcinoma patients. PMID: 17447064 Ref: Identification of a new hTERT-derived HLA-A*0201 restricted, naturally processed CTL epitope. PMID: 17464507 |
Ref: Epitope landscape in breast and colorectal cancer. PMID: 18245491 Ref: Cyclin D1-specific cytotoxic T lymphocytes are present in the repertoire of cancer patients: implications for cancer immunotherapy. PMID: 18927298 |
Ref: Identification of an immunogenic HLA-A*0201-binding T-cell epitope of the transcription factor PAX2. PMID: 19342968 Ref: Down-regulation of HLA Class I and NKG2D ligands through a concerted action of MAPK and DNA methyltransferases in colorectal cancer cells. PMID: 19569244 |
Ref: Methylation-specific ligation detection reaction (msLDR): a new approach for multiplex evaluation of methylation patterns. PMID: 21879293 |
Ref: Dendritic cell-based immunotherapy for colon cancer using an HLA-A*0201-restricted cytotoxic T-lymphocyte epitope from tumor-associated antigen 90K. PMID: 23524651 |
Ref: The translation elongation factor eEF2 is a novel tumorassociated antigen overexpressed in various types of cancers. PMID: 24589652 Ref: Predictive biomarkers for the outcome of vaccination of five therapeutic epitope peptides for colorectal cancer. PMID: 25075047 |